- CLINICAL BRIEFINGS
Bespoke vaccines can elicit long-lived immune activity against pancreatic cancer
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
£14.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
£199.00 per year
only £3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-025-00470-z
Figure 1 is published under a CC BY 4.0 licence.
References
Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. CA Cancer J. Clin. 73, 17–48 (2023).
Balachandran, V. P. et al. Nature 551, 512–516 (2017).
Łuksza, M. et al. Nature 606, 389-395 (2022).
Rojas, L. A. et al. Nature 618, 144–150 (2023).
Guasp, P., Reiche, C., Sethna, Z. & Balachandran, V. P. Cancer Cell 42, 1163–1184 (2024).